OncoMatch/Clinical Trials/NCT07645872
Clinical Data Collection of Patients Treated With High Intensity Focused Ultrasound (HIFU) by the Focal One for Their Prostate Cancer.
Is NCT07645872 recruiting? Yes, currently enrolling (Oct 2026).
The aim of the registry is to gather real-life data to evaluate the clinical performance and safety of medical devices in patients who have been treated with HIFU thank to the Focal One device for their prostate cancer.
Check if I qualifyExtracted eligibility criteria
Cancer type
Prostate Cancer
Demographics
Prior therapy
Must have received: high intensity focused ultrasound — prostate cancer
Being treated for prostate cancer with the Focal One device
Structured fields extracted by AI. May contain errors — verify against the official protocol.
Frequently asked questions
Is NCT07645872 currently recruiting?
Yes, this trial is currently recruiting patients.
Is prior treatment required for enrollment?
Yes. Patients must have previously received high intensity focused ultrasound.
Is this trial open to female patients?
No. This trial enrolls male patients only.
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualifyRelated pages